0
Critical Care |

Disseminated Thrombosis: A Stormy Presentation of a Myeloproliferative Disorder

Sheetal Gandotra, MD; Gbolahan Ogunbayo, MD; Siddharth Bansal, MD; Akash Agarwal, MD
Author and Funding Information

Rochester General Hospital, Rochester, NY


Chest. 2014;146(4_MeetingAbstracts):298A. doi:10.1378/chest.1991795
Text Size: A A A
Published online

Abstract

SESSION TITLE: Critical Care Student/Resident Case Report Posters II

SESSION TYPE: Medical Student/Resident Case Report

PRESENTED ON: Tuesday, October 28, 2014 at 01:30 PM - 02:30 PM

INTRODUCTION: Polycythemia vera (PCV) is a unique myeloproliferative disorder (MPD) characterized by overproduction of erythrocytes and possibly granulocytes and platelets, a phenotype caused by the JAK2 mutation. PCV accounts for 10-40% of cases of Budd-Chiari syndrome (BCS), a rare condition resulting from obstruction of hepatic venous outflow. We present a critical care case of PCV with rapidly progressing disseminated thrombosis, initially presenting as BCS in a previously healthy patient.

CASE PRESENTATION: A 46-year-old male with no significant medical history presented with progressive abdominal distention, malaise and dyspnea on minimal exertion of three weeks duration. He described early satiety, diarrhea, orthopnea and decreased urination. He drank alcohol rarely, denied illicit substance use, chemical exposures and recent respiratory illness. He took no medications. Exam revealed a distressed hypotensive male who was alert and oriented. Other significant findings included abdominal distension, engorged superficial abdominal veins and leg edema. Laboratory tests showed leukocytosis, thrombocytosis and evidence of renal and liver failure. Toxicology and hepatitis panels were negative. Abdominal CT showed moderate ascites with SAAG 1.8, suggesting portal hypertension. Abdominal doppler US showed acute thrombosis of hepatic, portal and splenic veins. TPA was administered, followed by heparin and warfarin. Hypercoagulable workup later revealed JAK2 mutation, confirming PCV as underlying etiology for his BCS and disseminated thrombosis. Therapeutic phlebotomy and hydroxyurea were also initiated. Unfortunately, his hospital course was complicated by further thrombosis leading to a right parietal lobe infarction, disseminated intravascular coagulopathy, decompensated multi-organ failure and ultimately, death.

DISCUSSION: This case illustrates disseminated thrombosis, including Budd-Chiari syndrome from an aggressive myeloproliferative disorder with impressive hepatoportal tree thrombosis as the first manifestation of PCV. BCS treatment entails correction of liver functions and ascites by reducing hepatic congestion and preventing further thrombosis with anticoagulation. In some instances, invasive procedures such as TIPS, balloon dilation or stenting of hepatic veins are required. This patient’s extensive thrombosis, DIC and rapid decompensation made him a poor candidate for any invasive procedure.

CONCLUSIONS: This unusually rapid course of Jak2-positive MPD with extensive thrombosis of the portal tree, manifested many known complications of BCS as well as unusual manifestations of thrombosis with an eventual fatal outcome.

Reference #1: Menon KV, Shah V, Kamath P. The Budd-Chiari Syndrome. N Engl J Med. 2004;350:578-585.

Reference #2: Valla D, Casadevall N, Lacombe C, et al. Primary myeloproliferative disorder and hepatic vein thrombosis: a prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med. 1985;103(3):329-334.

DISCLOSURE: The following authors have nothing to disclose: Sheetal Gandotra, Gbolahan Ogunbayo, Siddharth Bansal, Akash Agarwal

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543